113 related articles for article (PubMed ID: 9273234)
1. [Soluble class HLA antigens in serum of patients with brain tumors].
Turowski G; Gościński I; Gieracka D; Kedzierska A; Pawłowska E; Danilewicz B
Pol Merkur Lekarski; 1996 Dec; 1(6):410-1. PubMed ID: 9273234
[TBL] [Abstract][Full Text] [Related]
2. Immune responses in patients with gliomas.
Brooks WH; Caldwell HD; Mortara RH
Surg Neurol; 1974 Nov; 2(6):419-23. PubMed ID: 4372736
[No Abstract] [Full Text] [Related]
3. Behavior of non-classical soluble HLA class G antigens in human immunodeficiency virus 1-infected patients before and after HAART: comparison with classical soluble HLA-A, -B, -C antigens and potential role in immune-reconstitution.
Murdaca G; Contini P; Setti M; Cagnati P; Lantieri F; Indiveri F; Puppo F
Clin Immunol; 2009 Nov; 133(2):238-44. PubMed ID: 19762282
[TBL] [Abstract][Full Text] [Related]
4. [Detection of tumors specific humoral anitbody against brain tumors (author'stransl)].
Shimizu T; Kito K; Kubota S; Kitamura K; Takakura K
No Shinkei Geka; 1974; 2(11-12):747-56. PubMed ID: 4376831
[No Abstract] [Full Text] [Related]
5. [Catecholamine excretion in tumors of the cerebral hemispheres in the pre- and postoperative periods].
Khomitskaia LF
Vopr Neirokhir; 1973; 37(5):23-7. PubMed ID: 4360228
[No Abstract] [Full Text] [Related]
6. [Antigen-specific immunotherapy as a component of combined therapy for malignant brain tumors].
Ostanin AA; Tsentner MI; Khonina NA; Leplina OIu; Shevela EIa; Nikonov SD; Stupak VV; Chërnykh ER
Vopr Onkol; 2003; 49(2):170-5. PubMed ID: 12785199
[TBL] [Abstract][Full Text] [Related]
7. [On 6cases of glioblastomas of the cerebral hemisphere with long survival].
Caneschi S
Minerva Neurochir; 1969; 13(1):39-42. PubMed ID: 4320622
[No Abstract] [Full Text] [Related]
8. [Adrenal glucocorticoid function during removal of tumors of the cerebral hemispheres].
Khomitskaia LF
Vopr Neirokhir; 1972; 36(5):27-32. PubMed ID: 4356365
[No Abstract] [Full Text] [Related]
9. Soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Colombo BM; Contini P; Cagnati P; Pistorio A; Puppo F; Murdaca G
Allergy; 2008 Oct; 63(10):1335-8. PubMed ID: 18782112
[TBL] [Abstract][Full Text] [Related]
10. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
11. Sublingual immunotherapy reduces soluble HLA-G and HLA-A,-B,-C serum levels in patients with allergic rhinitis.
Ciprandi G; Contini P; Pistorio A; Murdaca G; Puppo F
Int Immunopharmacol; 2009 Feb; 9(2):253-7. PubMed ID: 19100344
[TBL] [Abstract][Full Text] [Related]
12. Differences in the blood serum levels of soluble HLA-G concentrations between the menstrual cycle phases and menopause in patients with ovarian endometriosis and uterine leiomyoma.
Basta P; Mach P; Pitynski K; Bednarek W; Klimek M; Zietek J; Zajac K; Wicherek L
Neuro Endocrinol Lett; 2009 Mar; 30(1):91-8. PubMed ID: 19300397
[TBL] [Abstract][Full Text] [Related]
13. [Detection and clinical significance of immune complexes in the sera of brain tumor patients].
Suda K; Ohtsuka S; Takeuchi J; Yamashita J; Oda Y; Handa H
No Shinkei Geka; 1982 Dec; 10(12):1283-8. PubMed ID: 6302540
[TBL] [Abstract][Full Text] [Related]
14. Increased level of soluble HLA class I antigens in systemic lupus erythematosus: correlation with anti-DNA antibodies and leukopenia.
Kippner L; Klint C; Sturfelt G; Bengtsson AA; Eriksson H; Truedsson L
J Autoimmun; 2001 Jun; 16(4):471-8. PubMed ID: 11437496
[TBL] [Abstract][Full Text] [Related]
15. Soluble HLA in saliva of patients with autoimmune rheumatic diseases.
Adamashvili I; Pressly T; Gebel H; Milford E; Wolf R; Mancini M; Sittg K; Ghali GE; Hall V; McDonald JC
Rheumatol Int; 2002 Jun; 22(2):71-6. PubMed ID: 12070679
[TBL] [Abstract][Full Text] [Related]
16. Glioblastoma patients exhibit circulating tumor-specific CD8+ T cells.
Tang J; Flomenberg P; Harshyne L; Kenyon L; Andrews DW
Clin Cancer Res; 2005 Jul; 11(14):5292-9. PubMed ID: 16033848
[TBL] [Abstract][Full Text] [Related]
17. [The features of the brain immune system in brain neoplasms].
Starchenko AA; Khil'ko VA; Komarets SA; Shulev IuA; Ivanteeva EP; Bikmullin VN; Prilukova TI
Zh Vopr Neirokhir Im N N Burdenko; 2002; (4):22-6; discussion 26-7. PubMed ID: 12608143
[TBL] [Abstract][Full Text] [Related]
18. [Brain scintigraphy and neuroradiological examinations in the postoperative care of brain-tumor patients].
Otto H; Clar HE; Fiebach O; Heissen E; Sauer J
Med Welt; 1975 Feb; 26(8):316-9. PubMed ID: 163424
[No Abstract] [Full Text] [Related]
19. Serum acute-phase proteins and immunoglobulins in patients with gliomas.
Weiss JF; Morantz RA; Bradley WP; Chretien PB
Cancer Res; 1979 Feb; 39(2 Pt 1):542-4. PubMed ID: 83910
[TBL] [Abstract][Full Text] [Related]
20. Soluble HLA class I and class II molecules in relapsing-remitting multiple sclerosis: acute response to interferon-beta1a treatment and their use as markers of disease activity.
Minagar A; Adamashvilli I; Jaffe SL; Glabus MF; Gonzalez-Toledo E; Kelley RE
Ann N Y Acad Sci; 2005 Jun; 1051():111-20. PubMed ID: 16126950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
